Nadim Ahmed
President and CEO at Cullinan Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cullinan Therapeutics Inc., 3 years.
Cullinan Therapeutics Inc.
Director · President and CEO
Chief executive roles
Cullinan Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2025 | Cullinan Therapeutics Inc. | Open-market sale | −12,529 | $8.53 | $106,872 |
| Feb 19, 2025 | Cullinan Therapeutics Inc. | Grant or award | +180,000 | — | — |
| Dec 24, 2024 | Cullinan Therapeutics Inc. | Open-market sale | −8,400 | $11.87 | $99,708 |
| Feb 22, 2024 | Cullinan Therapeutics Inc. | Grant or award | +160,000 | — | — |
| Dec 26, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −4,272 | $9.24 | $39,473 |
| Jun 28, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −759 | $11.40 | $8,653 |
| May 23, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −707 | $9.15 | $6,469 |
| Apr 25, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −716 | $10.59 | $7,582 |
| Mar 23, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −706 | $10.51 | $7,420 |
| Feb 22, 2023 | Cullinan Therapeutics Inc. | Grant or award | +109,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.